NCT05021237View on ClinicalTrials.gov

Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2028

Conditions
Stage IV Cervical Cancer FIGO 2018Adenosquamous Carcinoma of CervixCervical CancerMetastasis
Interventions
RADIATION

Ultra-fractionated radiation therapy

Patients enrolled in this study are planned to receive systemic therapy. Imaging based Ultra-fractionated radiation therapy using a PULSAR technique, which is 5 pulses to gross tumor in pelvis.

Trial Locations (1)

75235

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

collaborator

Elekta Limited

INDUSTRY